Header Logo

Connection

LUMARIE SANTIAGO to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications LUMARIE SANTIAGO has written about Antibodies, Monoclonal.
LUMARIE SANTIAGO
Connection Strength
0.093
Antibodies, Monoclonal
  1. Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer. Oncotarget. 2024 Mar 19; 15:238-247.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.